Status:
UNKNOWN
Immunopathological Analysis in a French National Cohort of Membranous Nephropathy
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Membranous Nephropathy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
National cohort of all cases of membranous nephropathy (MN) during a 1 year period in France, based on a pathological and/or serological diagnostic, collecting the data on: * incidence of MN * preval...
Detailed Description
Membranous nephropathy is a rare auto-immune disease, yet a major cause of nephrotic syndrome in adults. It is characterised by the deposition of antigen-antibody complexes on the glomerular basement ...
Eligibility Criteria
Inclusion
- Age 18 years or more
- Biopsy on a native kidney consistent with MN and/or positivity for serum anti-PLA2R1 and/or anti-THSD7A antibodies
- Signed informed consent
Exclusion
- Diagnosis error based on the kidney biopsy staining or on serology analyses for the positivity for anti-PLA2R1 and/or anti-THSD7A
- Patients unable to give an informed consent
- Patients withdrawing an informed consent
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2024
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04326218
Start Date
July 1 2020
End Date
July 1 2024
Last Update
April 7 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.